| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 3.422 | 3.616 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 9.293 | 40.719 | 5.655 | 2.028 |
| Total Expenses - EUR | - | - | - | - | - | - | 14.240 | 53.623 | 22.475 | 2.256 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -4.947 | -12.905 | -16.820 | -228 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -4.947 | -12.972 | -16.856 | -228 |
| Employees | - | - | - | - | - | - | 3 | 3 | 3 | 0 |
Check the financial reports for the company - Bio Dralbin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 20.227 | 15.341 | 13.256 | 11.154 |
| Current Assets | - | - | - | - | - | - | 876 | 1.571 | 171 | 178 |
| Inventories | - | - | - | - | - | - | 853 | 1.564 | 179 | 178 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | - | 22 | 7 | -8 | 0 |
| Shareholders Funds | - | - | - | - | - | - | -4.907 | -17.894 | -34.696 | -34.730 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 12.671 | 19.465 | 34.867 | 34.908 |
| Income in Advance | - | - | - | - | - | - | 19.906 | 15.341 | 13.256 | 11.154 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8292 - 8292" | |||||||||
| CAEN Financial Year |
8292
|
|||||||||
Comments - Bio Dralbin S.r.l.